$BDN

This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - argenx (NASDAQ:ARGX), Brandywine Realty Tr (NYSE:BDN)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Original reporting
Benzinga · Avi Kapoor
Published Nov 24, 2025, 12:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 25, 2025, 12:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - argenx (NASDAQ:ARGX), Brandywine Realty Tr (NYSE:BDN) — source image
Decision brief

The 30-second read

$BDNBullishLow
01

Why it matters

While some sectors show mild positive sentiment, overall market uncertainty suggests limited immediate trading opportunities.

02

Market read

The news primarily affects biotech and real estate sectors with limited broader market implications.

03

What to watch

Broader macroeconomic factors and upcoming earnings reports could override sector-specific sentiment.

Timing: Short-term (next 1-3 days)

Background

Recent analyst downgrades and sentiment shifts indicate a cautious outlook among Wall Street professionals.

Company-level read

Ticker impact

$BDNBullishMedium confidence
Context

Moderately relevant with a somewhat bullish sentiment, relevant for traders focusing on real estate.

Expected impact

Possible modest appreciation in stock price.

Evidence & confidence

The sentiment indicates potential for short-term gains, but broader market factors should be considered.

Market effects

The news may influence real estate and biotech sectors modestly, with limited broader market impact.

Primarily US-focused, with minimal international effects.

Low; the news pertains mainly to US equities and sectors.

Counterpoint

The downgrades and analyst sentiment shifts could signal underlying issues not yet reflected in prices, suggesting caution.

Key entities

  • Argenx

    A biotech firm focused on immunology and oncology therapies.

  • Brandywine Realty Trust

    A real estate investment trust focusing on office and industrial properties.

Related articles

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.

$BKRMed

Baker Hughes (BKR) Lands Multi-Year Contract with Pakistan’s OGDC

Baker Hughes (BKR) secured a multi-year contract with Pakistan's OGDC to enhance production from mature oil and gas fields. The deal involves assessing 120 wells and providing tailored redevelopment plans. Baker Hughes aims to use AI and other technologies to improve flow assurance and restore production. The contract aligns with Baker Hughes' strategy to diversify revenue and reduce reliance on short-term drilling cycles, as evidenced by a 49% YoY increase in orders to $10.5 billion in Q2. Howe

$AAPLMed

Tim Cook Delivered a 2,720% Total Return Over 15 Years. Here's Whether John Ternus Can Do the Same for Apple Investors.

Tim Cook stepped down as Apple CEO after 15 years, delivering 2,720% total returns. New CEO John Ternus faces challenges, including margin pressure from rising memory costs. Apple is set to launch new iPhone models this week. iPhone sales grew over 20% in recent quarters, but management expects slower growth. Apple stock fell on margin concerns despite briefly surpassing $5 trillion.